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CD47 Deficiency Protects Mice From
Diet-induced Obesity and Improves
Whole Body Glucose Tolerance and
Insulin Sensitivity
Hasiyeti Maimaitiyiming*, Heather Norman*, Qi Zhou & Shuxia Wang
Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY 40536; Lexington Veterans Affairs
Medical Center, Lexington, KY.
CD47 is a transmembrane protein with several functions including self-recognition, immune cell
communication, and cell signaling. Although it has been extensively studied in cancer and ischemia, CD47
function in obesity has never been explored. In this study, we utilized CD47 deficient mice in a high-fat diet
induced obesity model to study for the first time whether CD47 plays a role in the development of obesity
andmetabolic complications.Male CD47 deficient andwild type (WT) controlmice were fedwith either low
fat (LF) or high fat (HF) diets for 16 weeks. Interestingly, we found that CD47 deficient mice were protected
fromHF diet-induced obesity displaying decreased weight gain and reduced adiposity. This led to decreased
MCP1/CCR2 dependentmacrophage infiltration into adipose tissue and reduced inflammation, resulting in
improved glucose tolerance and insulin sensitivity. In addition, CD47 deficiency stimulated the expression
of UCP1 and carnitine palmitoyltransferase 1b (CPT1b) levels in brown adipose tissue, leading to increased
lipid utilization and heat production. This contributes to the increased energy utilization and reduced
adiposity observed in these mice. Taken together, these data revealed a novel role for CD47 in the
development of obesity and its related metabolic complications.
O
besity and its-associated insulin resistance is rampant within the United States and other developed
nations. Previous studies from our lab and others suggest that thrombospondin 1 (TSP1) plays an
important role in obesity-associated chronic inflammation and insulin resistance (IR)1–4. We demon-
strated that TSP1 deficiency did not affect the development of high-fat diet induced obesity. However, TSP1
deficiency reduced macrophage accumulation in adipose tissue and protected against obesity related inflam-
mation and insulin resistance3. These data suggest that TSP1 plays an important role in regulating macrophage
function and mediating obesity-induced inflammation and insulin resistance. However, the mechanisms of the
pro-inflammatory effect elicited by TSP1 under obese conditions remain to be determined.
TSP1, a 420–450 kDa homotrimer, is a multifunctional matricellular protein composed of several domains
that can interact with different cell surface receptors5–16. CD47 is one of the TSP1 receptor and a trans-membrane
glycoprotein cell receptor that belongs to the immunoglobulin superfamily17. CD47 expression can be seen in
various tissues and cell types throughout the body, ranging frommicroglia to red blood cells18,19.Wide expression
suggests that CD47 is active or necessary in several different cellular pathways including immunity and self-
recognition, inflammation, cellular adhesion, stress response, cell survival, and vascular function20–24. It has been
shown that TSP1-CD47 interaction inhibits NO/cGMP/PKG signaling in vascular smoothmuscle cells and plays
a role in vasoconstriction and inflammation22,25–27. However, it is unknown whether the pro-inflammatory effect
elicited by TSP1 under obese conditions is mediated by CD47.
In the current study, we determined whether TSP1 promotes obesity-associated inflammation and insulin
resistance is through interaction with its receptor-CD47. We utilized CD47 deficient and WT mice in a diet-
induced obesity paradigm. CD47 deficient mice challenged with a HF diet had several protective phenotypes as
previously observed in TSP1 deficient mice including decreased obesity-associated inflammation and improved
glucose tolerance and insulin sensitivity3. However, one different phenotype was observed between CD47 defi-
cient mice and our previous HF-fed TSP1 deficient mice3, which was the significant changes in body weight.
Current studies have shown that CD47 deficiency protected mice from HF diet induced obesity; while TSP1
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deficiency had no effect on diet-induced obesity after 16 weeks of HF
feeding. Moreover, CD47 deficiency increased energy expenditure,
heat production and core body temperature partially relating to
brown adipose tissue and/or skeletal muscle functional changes.
Together, data from this study revealed a novel role for CD47 in
regulation of energy homeostasis and the development of obesity,
suggesting that CD47 may serve as a potential therapeutic target to
combat obesity and metabolic complications.
Results
CD47 deficiency protects mice from diet-induced obesity. To
assess the metabolic role of CD47 in mice, CD47 deficient mice
and WT controls were challenged with either a low fat (LF, 10%
kcal from fat) or high fat (HF, 60% kcal from fat) diet for 16
weeks. Under LF diet, although CD 47 deficient mice had a trend
of decrease in body weight as compared to WT mice, no significant
changes were observed throughout the study (Fig. 1A). When
challenged with HF diet, CD47 deficient mice exhibited
significantly reduced body weight starting from 7 weeks’ feeding
till the end of the study. These mice gained less weight than HF-
fed WT mice (Fig. 1B). At the end of study, body composition was
determined in mice by using EchoMRI. There was significantly
reduced fat mass in HF-fed CD47 deficient mice as compared to
HF-fed WT mice (Fig. 1C), which was in agreement with the
absolute weight of different adipose tissue depots (Fig. 1E). Lean
mass was comparable in HF-fed CD47 deficient mice and WT
mice (Fig. 1D). Consistent with the decreased adiposity, HF-fed
CD47 deficient mice had reduced leptin levels (ng/ml, WT HF:
14.4 6 4.89 vs. CD47-/- HF: 6.83 6 1.09, p , 0.05). Moreover,
plasma total cholesterol (TC) and free fatty acid (FFA) levels were
significantly reduced in HF-fed CD47 deficient mice (TC (mg/dl),
WT HF: 115.08 6 7.25 vs. CD47-/- HF: 80.04 6 7.87, p, 0.01; FFA
(mEq/L), WT HF: 0.34 6 0.01 vs. CD47-/- HF: 0.28 6 0.02, p ,
0.05). Together, these data suggests that CD47 deficiency protects
mice from diet-induced obesity.
CD47 deficient mice on the HF diet showed reduced systemic and
adipose tissue inflammation. Systemic as well as adipose tissue
inflammation were determined in four groups of mice. As shown in
Fig. 2A,B, HF-fed CD47 deficient mice had significant reduction in
plasma TNF-a and IL-6 levels. In addition to the reduced plasma pro-
inflammatory cytokines, plasma anti-inflammatory cytokine-IL-10
levels were significantly increased in HF-fed CD47 deficient mice as
compared to HF-fed WT mice or to LF-fed CD47 deficient mice
(Fig. 2C), suggesting that the interaction between diet composition
and genotype contributes to the IL-10 secretion. In addition to
systemic inflammation, adipose tissue inflammation status was
determined. Visceral adipose tissue has been suggested to be the
primary source of cytokine and adipokine release within obesity-
associated inflammation28. Moreover, increased accumulation of
adipose tissue macrophages is a significant contributor to obesity-
induced chronic inflammation29–31. Therefore macrophage infiltration
into adipose tissue was determined by immunohistochemical staining
for macrophage marker-F4/80. As shown in Fig. 3A, HF-fed WT
controls had robust positive staining of F4/80 and crown-like
Figure 1 | CD47 deficient mice were protected from high fat diet-induced obesity. Eight week old male CD47 deficient mice and wild type C57BL6
controls were fedwith low fat (LF) or high fat (HF) diet for 16weeks.Weekly bodyweight (A) and bodyweight gain (B)were shown. Fat (C) and leanmass
(D) of mice were measured by EchoMRI. (E) Absolute weight of white and brown adipose tissues was measured immediately following sacrifice. Data are
presented as mean 6 SE (n 5 7 mice/group), *p, 0.05, **p, 0.01. EAT: epididymal adipose tissue; MAT: mesenteric adipose tissue; PAT: perirenal
adipose tissue; SAT: subcutaneous adipose tissue; BAT: brown adipose tissue.
www.nature.com/scientificreports
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structures, yet HF-fed CD47 deficient mice had minimal positive
staining, suggesting a decreased presence of macrophages. We
confirmed this staining result with qPCR and demonstrated that HF-
fed WT controls had a significant increase in F4/80 expression in
adipose tissue, which was reduced in HF-fed CD47 deficient mice
(Fig. 3B). Moreover, CD11c and TNF-a levels were increased in
adipose tissue from HF-fed WT mice, but decreased in HF-fed
CD47deficient mice (Fig. 3B). Together, these data indicate that HF-
fed CD47 deficient mice had reduced macrophage infiltration into
adipose tissue and decreased systemic and adipose tissue inflammation.
To determine the mechanism of reduced macrophage infiltration
in adipose tissue from HF-fed CD47 deficient mice, we examined
MCP1 and CCR2 levels. MCP1, an inflammatory chemokine
responsible for monocyte migration, and its dominant receptor
CCR2 are suggested to be responsible for a significant amount of
monocyte infiltration into inflamed adipose tissue29. We found that
HF-fed CD47 deficient mice demonstrated a reduction inMCP1 and
CCR2 levels in adipose tissue (Fig. 3B), which might be due to the
reduced adiposity in these mice. In addition, this result could explain
the significant decrease in macrophage infiltration in adipose tissue
fromCD47 deficientmice, whichwas supported by an in vitromigra-
tion studies using isolated macrophages from HF fed WT and CD47
deficient mice. We found that WT macrophages had increased
MCP1 stimulated migration; while macrophages from CD47 defi-
cientmice showed reducedmigration in response toMCP1 (Fig. 3C).
Together, these data suggest that CD47 regulates diet-induced adip-
Figure 2 | HF-fed CD47 deficient mice displayed reduced systemic inflammation compared to HF-fed wild type controls. Plasma TNF-a (A),
IL-6 (B), and IL-10 (C) levels were measured by ELISA as described in Methods. Data are presented as mean 6 SE (n 5 7 mice/group), *P, 0.05 and
** P , 0.01.
Figure 3 | HF-fed CD47 deficient mice had decreased adipose tissue macrophage infiltration and inflammation. (A) Macrophage accumulation in
epididymal adipose tissue was determined by anti-F4/80 staining. The positive staining showed brown color and indicated by arrow head. The
representative images are shown. Scale bars represent 100 mm. (B) Expression of pro-inflammatory cytokines in epididymal adipose tissue was
determined by real-time PCR and normalized to 18S RNA. (C) Bone marrow cells from HF-fed WT and CD47 deficient mice were isolated and
differentiated into macrophages. Migration of these cells were measured basally and upon MCP1 (50 ng/ml) stimulation using modified Boyden
Microchemotaxis Chamber. Data are presented as mean 6 SE (n 5 7 mice/group), *p , 0.05 and **p , 0.01.
www.nature.com/scientificreports
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ose tissue macrophage infiltration and inflammation through a
MCP1/CCR2 dependent pathway.
CD47 deficient mice on the HF diet showed improved whole body
glucose homeostasis. The liver morphology was determined in the
current study. We found that CD47 deficiency protected mice from
hepatosteatosis when fed with HF diet, which was demonstrated by
reduced liver weight, oil red-O staining in liver sections and liver
triglyceride levels (Fig. 4).
To determine the whole body glucose homeostasis, we performed
glucose tolerance (GTT) and insulin sensitivity tests (ITT) in WT
and CD47 deficient mice. As shown in Fig. 5, glucose tolerance
and insulin sensitivity were significantly improved in HF-fed
CD47-/- mice as compared to HF-fed WT mice, suggesting that
CD47 deficiency protects mice from diet-induced glucose intol-
erance and insulin resistance.
Energymetabolism inWTorCD47 deficientmice under either LF
or HF feeding conditions. We have shown that CD47 deficiency
protects mice from diet-induced obesity. To further elucidate its
mechanism, we examined the energy balance in both WT and
CD47 deficient mice. Daily cumulative food consumption was
measured and there was no significant difference between either
genotype or diet type (Fig. 6A). However, CD47 deficient mice
displayed elevated energy expenditure (normalized to total body
mass), heat production, core body temperature, or total activity
compared to WT mice under HF feeding conditions in either
light or dark cycle (Fig. 6B–E). Together, these data suggest
that the protection against HF diet induced weight gain and fat
gain in CD47 deficient mice might be due to increased energy
utilization.
Metabolic gene expression in skeletal muscle from LF or HF fed
WT and CD47 deficient mice.To further determine themechanism
of increased energy utilization in HF-Fed CD47 deficient mice, first,
we analyzed the expression of multiple genes in skeletal muscle that
relate tomitochondria function and fuel utilization. The rationale for
this analysis was based on the previous report showing that skeletal
muscle from CD47 deficient mice had greater number of
mitochondria and improved function32, which suggested a possible
contribution of skeletal muscle to the metabolic phenotype observed
in the current study. Therefore, mitochondria DNA copy number
and expression of a series genes relating to mitochondria oxidative
function and fatty acid catabolismwere analyzed. The results showed
that mitochondria DNA copy number was significantly increased in
CD47 deficient mice compared to WT mice under either LF or HF
feeding conditions (Fig. 7A). However, expression levels of genes
relating to mitochondria oxidative function and fatty acid
catabolism were comparable in CD47 deficient mice compared to
WT mice under either LF or HF feeding conditions (Fig. 7B),
suggesting that skeletal muscle functional change might be not the
major contribution to the increased energy utilization phenotype in
HF-fed CD47 deficient mice.
Morphology and metabolic gene expression in brown adipose tissue
from LF or HF fed WT and CD47 deficient mice. Recently, brown
Figure 4 | CD47 deficiency prevents lipid accumulation in liver after HF diet feeding. Lipid accumulation in liver from four groups of mice was
determined by measuring liver weight (A), staining liver sections by Oil-red-O (B), and quantification of triglyceride from liver extracts (C).
The representative images of Oil-red-O staining are shown. Scale bars represent 100 mm.Data are presented asmean6 SE (n5 7 mice/group), *P, 0.05.
www.nature.com/scientificreports
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adipose tissue (BAT) emerged as an important player in energy
metabolism33. However, whether CD47 regulates BAT function and
contributes to diet-induced obesity is unknown. First, we found that
diet-induced obesity significantly up-regulated CD47 protein levels in
BAT in wild type mice (Fig. 8A). Although interscapular BAT weight
was not different between WT and CD47-/- mice under either LF or
HF feeding conditions (Fig. 1E), histology showed a decrease in
intracellular lipid droplet size in BAT of HF-fed CD47 deficient mice
compared to HF-fed WT mice, reflected by a decrease in relative lipid
area (Fig. 8B, C). Moreover, we analyzed mitochondria DNA copy
number and a series of genes relating to mitochondria oxidative
function and fatty acid catabolism. As shown in Fig. 8D, no
significant changes in mitochondria DNA copy number in BAT was
observed in CD47-/- mice compared to WT mice, suggesting that
CD47 does not affect mitochondria biogenesis in BAT. In addition,
mRNA levels of UCP1 and carnitine palmitoyltransferase 1B (CPT1b)
in BAT were significantly increased in HF-fed CD47 deficient mice
(Fig. 8E). BAT expends a large amount of energy through
mitochondria b-oxidation and by uncoupling of the mitochondria
proton gradient from ATP production. This uncoupling results in
heat production or thermogenesis, accomplished by UCP1 located in
the inner mitochondria membrane34,35. CPT1, located on the outer
mitochondrial membrane, is the first and rate-limiting step for fatty
acid transporting into themitochondria for utilization36. Therefore, this
data suggests that CD47 deficiency-mediated increased CPT1b
expression in BAT may lead to increased fatty acid uptake in
mitochondria and then activation of UCP1, resulting in increased
uncoupling and heat production (Fig. 6C,D).
cGMP/PKG signaling inWT or CD47 deficient mice under either
LF or HF feeding conditions. Studies have shown that CD47
activation via TSP1 can disrupt NO/cGMP/PKG signaling in
vascular cells23,37,38. Therefore, we determined whether cGMP/PKG
signaling in brown adipose tissue (BAT) or skeletal muscle was
changed in CD47-/- mice under either LF or HF feeding
conditions. As shown in Fig. 9A, under LF feeding conditions,
cGMP levels in BAT was increased in CD47-/- mice compared to
WTmice. HF diet feeding significantly reduced BAT cGMP levels in
WT or in CD47-/- mice compared to their LF controls. There was a
trend of increase in BAT cGMP levels in HF-fed CD47-/- mice
compared to HF-fed WT mice. For PKG-I protein levels in BAT,
under LF feeding conditions, no difference was found between WT
and CD47-/- mice. However, under HF feeding conditions, BAT
PKG-I protein levels were significantly increased in CD47-/- mice
compared to WT mice (Fig. 9B).
In addition to brow fat, cGMP/PKG signaling in skeletal muscle
was analyzed. We found that cGMP levels or PKG-I protein levels
were increased in LF-fed CD47-/-mice compared to LF-fedWTmice
(Fig. 9C, D). However, under HF feeding conditions, there was no
difference in cGMP or PKG-I levels betweenWT and CD47-/- mice.
Together, these data suggest that cGMP/PKG signaling was differ-
entially regulated by CD47 in BAT and skeletal muscle.
Figure 5 | HF-fed CD47 deficient mice had improved glucose tolerance and insulin sensitivity. Intraperitoneal glucose tolerance test (A) and insulin
sensitivity test (B) were performed in male CD47 deficient and littermate control mice after 15 weeks of HF or LF feeding. Data are presented as
mean 6 SE (n 5 7 mice/group), *P , 0.05 vs. HF CD47-/-; #P , 0.05; AUC: area under the curve.
www.nature.com/scientificreports
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Discussion
CD47 is a transmembrane protein with several functions including
self-recognition, immune cell communication, and cell signaling18,19.
Although it has been extensively studied in cancer and ischemia39–42,
CD47 function in obesity has never been explored. In this study, we
utilized CD47 deficient mice in a high-fat diet induced obesity model
to study for the first time whether CD47 plays a role in diet-induced
obesity and its associated metabolic complications. We found that
CD47 deficient mice were protected from HF diet-induced obesity
displaying decreased weight gain and reduced adiposity. This led to
decreased MCP1/CCR2 dependent macrophage infiltration into
adipose tissue and reduced inflammation, resulting in improved glu-
cose tolerance and insulin sensitivity. In addition, CD47 deficiency
stimulated the expression of UCP1 and CPT1b levels in brown adip-
ose tissue, leading to increased lipid utilization and heat production
and contributing to increased energy utilization and reduced adip-
osity in these mice. These data suggest a novel role for CD47 in
regulation of brown adipose tissue function and its contribution to
the development of obesity and dyslipidemia.
CD47 is a receptor for the matricellular protein-thrombospondin
1 (TSP1). Previous studies from our lab and others suggest that TSP1
plays a role in obesity-associated chronic inflammation and insulin
resistance (IR)1–4. Both TSP1 and CD47 expression in adipose tissue
was up-regulated under obese conditions2,4, suggesting that CD47
may mediate TSP1’s effect on diet-induced obesity and obesity-
associated complications. By feeding CD47 deficient mice with the
same diet (10% (LF) and 60% fat (HF) diet) for same periods (16
weeks) as we did before for TSP1 deficient mice3, we found that most
of the phenotypes observed in the TSP1 deficient mice undergoing
HF feedingwere replicated in CD47 deficientmice including reduced
macrophage infiltration into adipose tissue, reduced inflammation,
and improved glucose tolerance and insulin sensitivity. However,
one different phenotype was observed between CD47 deficient mice
and our previous HF-fed TSP1 deficient mice3, which was the sig-
nificant changes in body weight. Current studies showed that CD47
deficiency protected mice from HF diet induced obesity; while TSP1
deficiency had no effect on diet-induced obesity after 16 weeks of HF
feeding. This different phenotype suggests that TSP1-CD47 ligation
may not be involved in regulation of energy homeostasis under HF
feeding conditions. The novel CD47 ligands and their interaction on
energy balance and the development of obesity warrant further
investigation.
It has been shown that CD47 activation via TSP1 can disrupt NO-
cGMP signaling and that decreased NO-cGMP pathway contributes
to vascular inflammation as well as adipose tissue inflammation,
resulting in insulin resistance37,38. In agreement with these observa-
tions, HF-fed CD47 deficient mice showed decreased levels of cir-
culating proinflammatory cytokines as well as reduced inflammation
in adipose tissue. They also had improved glucose tolerance and
insulin sensitivity. Moreover, with reduced adiposity in HF-fed
CD47 deficient mice, these mice exhibited reduced expression of
MCP1 and CCR2 in adipose tissue. This was associated with reduced
macrophage infiltration into adipose tissue inHF-fed CD47 deficient
mice. Further in vitro analysis demonstrated that CD47 deficient
macrophages had significantly decreased migration compared to
WT cells upon stimulation with MCP1. The importance of MCP1
and CCR2 in adipose tissue macrophage recruitment and their con-
tribution to insulin resistance has been demonstrated by numerous
Figure 6 | Energy metabolism inWT and CD47 deficient mice under either LF or HF feeding conditions. Eight week old male CD47 deficient mice and
wild type littermate controls were fed with low fat (LF) or high fat (HF) diet for 16 weeks and housed in TSE chambers for indirect calorimetric
analysis. (A) Daily food intake was measured for 6 consecutive days. (B) Energy expenditure was normalized to total body mass during both the light and
dark cycles. (C) Heat production, (D) Core body temperature, and (E) Activity were shown during both the light and dark cycles. Data are presented as
mean 6 SE (n 5 4 mice/group), *P , 0.05; **p , 0.01; ***P , 0.001.
www.nature.com/scientificreports
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studies43–48. Thus, data from our study suggest that the effect of CD47
on macrophage infiltration into adipose tissue and the development
of chronic inflammation under obesity conditions is MCP1/CCR2
dependent.
In this study, we found that CD47 deficiency protected mice from
HF diet induced obesity, which was associated with increased energy
utilization. To determine themechanisms of increasedmetabolic rate
in HF-fed CD47 deficient mice, we analyzed skeletal muscle function
since a previous report showed that skeletal muscle from CD47 defi-
cient mice had greater number of mitochondria and improved skel-
etal muscle function32. Although we saw increased mitochondria
number in skeletal muscle from HF-fed CD47 deficient mice com-
pared to HF-fed WT mice, the expression of genes relating to mito-
chondria oxidative function or fatty acid catabolism in skeletal
muscle were comparable between WT and CD47 deficient mice
(Fig. 7). These data suggest that skeletal muscle functional change
might be not the major contribution to the increased energy expend-
iture phenotype in HF-fed CD47 deficient mice.
The contribution of adipose tissue function to the increased meta-
bolic rate in HF-fed CD47 deficient mice was also analyzed. The
rationale for such study is based on previous reports showing that
increased cGMP/PKG signaling pathway stimulates brown adipo-
cyte differentiation49, promotes healthy expansion and browning of
white adipose tissue50, stimulates white adipose tissue lipolysis and
cold induced brown fat thermogenesis51. In the current study, we
found that obesity stimulated CD47 expression in brown adipose
tissue (BAT). BAT is highly vascularized, highly innervated by the
sympathetic nervous system, and is densely packed with mitochon-
dria. BAT expends a large amount of energy through mitochondria
b-oxidation and by uncoupling of the mitochondria proton gradient
fromATP production. This uncoupling results in heat production or
thermogenesis, accomplished by UCP1 located in the inner mito-
chondria membrane34,35. In the current study, we found that brown
fat mass and mitochondria DNA content was similar between WT
and CD47 deficient mice. UCP1 expression was not found in white
fat from either WT or CD 47 deficient mice under either LF or HF
feeding conditions (data not shown), suggesting there was no brown-
ing of white fat. Importantly, loss of CD47 caused significantly
increased UCP1 expression in brown fat under HF feeding condi-
tions. Consistently, we found that core body temperature was ele-
vated in HF-fed CD47 deficient mice, indicating the increased
thermogenesis. It is known that fatty acids are an important fuel
for thermogenesis. Lipolysis releases fatty acids that can be used
formitochondria oxidation and thermogenesis. Previously, we found
that activation of PKG signaling stimulates lipolysis in adipose tis-
sue51. In the current study, we demonstrated that cGMP and/or PKG
signaling was up-regulated in brown fat from CD47 deficient mice.
Moreover, the lipid accumulation in the brown fat was significantly
reduced in HF-fed CD47 deficient mice. Based on these data, we
speculate that CD47 deficiency stimulates lipolysis in brown fat via
activation of cGMP/PKG pathway. In addition, we found that the
carnitine palmitoyltransferase 1 (CPT1) was up-regulated in HF-fed
CD47 deficient mice compared to HF-fed WT mice. CPT1, located
on the outer mitochondrial membrane, is the first and rate-limiting
step for fatty acid transporting into the mitochondria for utiliza-
tion36. Therefore, CD47 deficiency may increase fatty acid transloca-
tion into mitochondria by fatty acid transporter CPT1 and then lead
to the activation of UCP1 in brown fat and increased heat produc-
tion. Our data suggest that CD47 mediated regulation of brown fat
function contributes to the metabolic phonotype observed in the
current study. However, to definitively demonstrate the effect of
brown fat cell derived CD47 on energy metabolism in diet-induced
obesity, the tissue specific CD47 deficient mice are required in future
studies.
In summary, for the first time, our studies demonstrate an import-
ant role for CD47 in regulating energy balance and the development
Figure 7 | Metabolic gene expression in skeletal muscle from LF or HF feeding WT or CD47 deficient mice. (A) Mitochondria DNA copy number in
skeletal mice from four groups of mice and (B) expression of metabolic genes including acylcoA Oxidase (ACO), Fatty acid transporter protein
(FATP1), Carnitine palmitoyltransferase 1b (CPT1b), UCP3, PGC-1a, COX I, COX III and ATPsyn by real-time PCR. Data are presented as mean 6 SE
(n 5 6–7 mice/group), *P , 0.05.
www.nature.com/scientificreports
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of obesity and its metabolic complications. CD47 deficiency protects
mice from HF diet-induced obesity through stimulation of energy
expenditure and heat production. In addition, CD47 deficiency
reduces obesity- associated metabolic complications including
decreased systemic and adipose tissue inflammation and hepatostea-
tosis, and improved glucose tolerance and insulin sensitivity. The
Figure 8 | Morphology and metabolic gene expression in brown adipose tissue from LF or HF feeding WT or CD47 deficient mice. (A) CD47 protein
levels in brown adipose tissue from LF or HF fed WT mice by immunoblotting (Cropped blots were used); (B) Representative images of HE
staining of brown adipose tissue from LF or HF fed CD47 deficient and WT mice. Images were obtained at x20. Scale bars represent 100 mm; (C)
Percentage lipid content in brown adipose tissue sections, as quantified using image analysis software. (D)Mitochondria DNA copy number by PCR and
(E) Expression of metabolic genes by real-time PCR. Data are presented as mean 6 SE (n 5 6–7 mice/group), *P , 0.05 and **p , 0.01.
Figure 9 | cGMP or PKG signaling in brown adipose tissue and skeletal muscle from LF or HF feedingWT or CD47 deficient mice. (A) cGMP levels in
brown adipose tissue from LF or HF fed WT mice by direct immunoassay; (B) PKG-I protein levels in brown adipose tissue from LF or HF fed WT
mice by immunoblotting (Cropped blots were used); (C) cGMP levels in skeletal muscle from LF or HF fedWTmice by direct immunoassay; (D) PKG-I
protein levels in skeletal muscle from LF or HF fed WT mice by immunoblotting (Cropped blots were used). Data are presented as mean 6 SE (n 5
6 mice/group), *P , 0.05 and **p , 0.01.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8846 | DOI: 10.1038/srep08846 8
results from this study suggest that CD47 may serve as a therapeutic
target of obesity and its related comorbidities.
Methods
Animal experimental protocol. All experiments were performed on eight week-old
male CD47-/- mice (C57BL6/J background from Jackson Laboratories) and same sex
and age-matched C57BL6/J controls. Mice were given a high fat (HF) (60% kcal from
fat; D12492, Research Diets, Inc, NJ) or low fat (LF) diet (10% kcal from fat; D12450B;
Research Diets, Inc, NJ) for 16 weeks with standard laboratory water. Each group
contained 7 mice. Body weight was measured weekly at the same time. Temperature
transponders (Implantable Programmable Temperature Transponder 300; BioMedic
Data Systems, Seaford, DE) were subcutaneously implanted into mice at the week 8
time point during diet challenge. The wireless reader system was utilized to measure
core body temperatures in both the light and dark cycles. At the end of the study, mice
were sacrificed. Blood was collected and adipose tissue depots and muscle were
harvested for various analyses. All experiments involving mice conformed to the
National Institutes of Health Guide for the Care and Use of Laboratory Animals and
were approved by the University of Kentucky Institutional Animal Care and Use
Committee.
Indirect calorimetry and body composition. Two weeks prior to the end of study,
mice were placed in TSE LabMaster chambers (TSE systems) individually for 5 days
for measurement of food intake, water intake and indirect calorimetry. Body
composition including lean and fat mass was measured by EchoMRI (Echo Medical
System) basally and after 16 weeks of HF/LF feeding.
Plasma parameters analysis. Plasma insulin, IL-6, TNFa, IL-10, leptin, and MCP1
(eBioscience, USA) were measured by ELISA. Plasma and liver triacylglycerol (TG),
non-esterified fatty acids (NEFA) and total cholesterol (Wako Chemicals, Richmond,
USA) levels were measured enzymatically.
Intraperitoneal glucose (GTT) and insulin (ITT) tolerance test. Glucose tolerance
and insulin tolerance were analyzed basally and after 15-weeks of HF or LF feeding.
Mice were fasted 6 hours before intraperitoneal injections of glucose (1 g/kg body
weight) or insulin (0.5 unit/kg body weight; Novolin R, Novo Nordisk Inc.). Blood
glucose concentrations were measured using a glucometer at 0, 15, 30, 60, and 120
minutes post injection.
Real-time quantitative PCR. Total RNA from frozen adipose tissue and skeletal
muscle were extracted using RNeasy Mini Kit (Qiagen, USA). RNA was reverse
transcribed to cDNA by High Capacity cDNA Reverse Transcription Kit (Invitrogen,
Carlsband, CA). Real-time quantitative PCR was performed on a MyiQ Real-time
PCR Thermal Cycler (Bio-Rad) with SYBR Green PCRMaster Kit (Qiagen, Valencia,
CA). Relative mRNA expression was calculated using the MyiQ system software as
previous reported3 and normalized to 18 s RNA levels. All primer sequences utilized
in this study are found in supplementary Table 1.
Mitochondrial DNA copy number. DNA was extracted from skeletal muscle or
brown adipose tissue by using QIAamp DNA mini kit (Qiagen). The relative
mitochondria DNA (mtDNA) copy numbers were determined by real-time PCR as
described previously3 and normalized to nuclear DNA (28 s). Primer sequences
utilized are shown in supplementary Table 1.
Brown adipose tissue histology. Interscapular brown adipose tissues or liver tissue from
all four groups of animals were embedded in paraffin, sectioned at 4 mm, and stained with
hematoxylin and eosin-stain by standard method. Intracellular lipid content for brown
adipose tissue was quantified by use of Nikon NIS-Elements BR software (NY, USA).
Oil RedO staining of liver tissue. Fresh frozen liver tissues were cryostat sectioned at
6 mm and fixed in 4% PFA for 10 min at room temperature (RT). Slides were blotted
in 60% isopropyl alcohol for 5 min, and then stained with filtered Oil Red O for
15 min at RT. Slides were rinsed once with distilled water, mounted, and cover
slipped with warmed glycerol gelatin.
Liver triglyceride measurement. For analysis of liver triglyceride (TG) content,
approximately 50 mg of liver was placed into 500 mL of chilled Krebs Ringer
Phosphate (118 mM NaCl, 5 mM KCl, 13.8 mM CaCl2, 1.2 mM MgSO4, 0.016%
KH2PO4, 0.211% NaHCO2) and each sample was sonicated for ten times
(30 seconds/time). The homogenate was centrifuged at 2,000 3 g for 10 min at 4uC,
and 10 mL of the supernatant was then removed for triglyceride analyses. Triglyceride
content was measured using Wako triglyceride method kit (Richmond, USA).
Immunohistochemical staining. Epididymal adipose tissue was fixed and embedded
in paraffin. Paraffin-fixed adipose tissues were cut into 4 mmsections and placed onto
slides. Sections were deparaffinized, rehydrated in graded mixtures of ethanol/water,
pretreated by boiling in citrate buffer (pH 6.0), and endogenous peroxidase activity
was blocked with 3% H2O2 for 30 min at room temperature (RT). The sections were
incubated with a rat anti-mouse F4/80 antibody (AbD Serotec, Raleigh, NC) in
blocking buffer for 1 hour at RT. Then, slides were washed, incubated with
biotinylated secondary antibody for 30 min, and thenwashed againwith PBS. Finally,
peroxidase substrate diaminobenzidine (Vector Lab) was applied and incubated for
30 min. The slides were rinsed and counterstained with hematoxylin. Mounting
solution and coverslips were added. Images were acquired with a Nikon Edipse 55i
microscope.
Macrophage migration assay. Bone-marrow derived cells were isolated from femurs
and tibias of male WT and CD47 deficient mice fed with HF diet. These cells were
cultured 7 days in RPMI-1640 media containing 20% FBS, 25 ng/mlM-CSF (Sigma),
and penicillin/streptomycin to allow differentiation into mature macrophages.
Ability of these macrophages to migrate toward MCP-1 (50 ng/ml) was determined
using modified Boyden Microchemotaxis Chamber. Briefly, cells were washed twice
with PBS, counted and loaded into the upper chambers of Transwell, while the lower
chambers were filled with DMEM media with or without MCP-1 (50 ng/ml).
Transwell plates were then incubated at 37uC for 6 hours. The upper inserts with
membrane were removed and fixed in cold methanol and stained with crystal violet
(Sigma). Cells were counted from five different fields for each well. Results were
expressed as a migration index under the high magnification field.
cGMPmeasurement. cGMP levels in brown fat or skeletal muscles from LF orHF fed
WT or CD47-/- mice were measured by using the cGMP Direct Immunoassay Kit
(Colorimetric) fromBiovision. Frozen tissues were homogenized and the supernatant
was collected. cGMP levels in the supernatant weremeasured and calculated based on
the cGMP standard curve following the instruction manual.
Western blotting analysis. Brow fat or skeletal muscle was homogenized in lysis
buffer. After concentration being measured, homogenates were subjected to SDS-
PAGE gel under reducing conditions and transferred onto a nitrocellulose
membrane. After blocking, the membrane was incubated with anti-GAPDH
(Millipore), anti-CD47 (BD Biosciences), or anti-PKG-I (BD Biosciences) antibodies
at 4uC overnight. After washing, the membrane was incubated with horseradish
peroxidase-conjugated secondary antibodies (Jackson Labs). The reaction was
visualized by using an enhanced chemiluminescence system (Pierce). Immunoblots
were analyzed by scanning densitometry and quantified byQuantity One gel Analysis
software (Bio-Rad Laboratories).
Statistical analysis. Data are expressed as the mean value 6 SE. Statistical
significance was assessed using ANOVA with Bonferroni ad hoc. A p value of,0.05
was considered statistically significant.
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